Generalized estimating equation models examining secondary outcomes across never-HCT, pre-HCT, and post-HCT groups after adjusting for covariates plus/minus change over time
Measure . | Parameter . | Comparison . | Estimate (95% CI) . | P . |
---|---|---|---|---|
QOL (FACT-G) (greater than mean - 0.5 standard) | Group | Never-HCT | Reference | |
Group | Pre- vs never-HCT | 1.25 (0.86-1.82) | .2512 | |
Group | Post- vs never-HCT | 1.37 (0.77-2.45) | .2859 | |
Group change over time∗ | Never-HCT | Reference | ||
Group change over time∗ | Pre- vs never-HCT | 1.02 (0.94-1.10) | .6542 | |
Group change over time∗ | Post- vs never-HCT | 0.97 (0.92-1.03) | .3057 | |
QOL (EuroQOL 5-dimensions index) (>33rd percentile) | Group | Never-HCT | Reference | |
Group | Pre- vs never-HCT | 1.26 (0.89-1.79) | .1859 | |
Group | Post- vs never-HCT | 1.41 (0.82-2.43) | .2098 | |
Group change over time∗ | Never-HCT | Reference | ||
Group change over time∗ | Pre- vs never-HCT | 1.00 (0.92-1.10) | .9112 | |
Group change over time∗ | Post- vs never-HCT | 1.00 (0.95-1.04) | .8568 | |
Depressive symptoms (PHQ-9) (<10) | Group | Never-HCT | Reference | |
Group | Pre- vs never-HCT | 1.04 (0.72-1.49) | .8368 | |
Group | Post- vs never-HCT | 2.01 (1.06-3.81) | .0323 | |
Group change over time∗ | Never-HCT | Reference | ||
Group change over time∗ | Pre- vs never-HCT | 1.19 (1.05-1.35) | .0055 | |
Group change over time∗ | Post- vs never-HCT | 0.95 (0.89-1.01) | .0913 | |
Social activities (social activity log) (≥1.13) | Group | Never-HCT | Reference | |
Group | Pre- vs never-HCT | 2.06 (1.40-3.04) | <.001 | |
Group | Post- vs never-HCT | 1.27 (0.70-2.32) | .4344 | |
Group change over time∗ | Never-HCT | Reference | ||
Group change over time∗ | Pre- vs never-HCT | 0.93 (0.87-0.99) | .0346 | |
Group change over time∗ | Post- vs never-HCT | 1.00 (0.95-1.05) | .9789 | |
Perceived social support (ENRICHD social support inventory) (greater than mean - 0.5 standard) | Group | Never-HCT | Reference | |
Group | Pre- vs never-HCT | 1.76 (1.21-2.57) | .0033 | |
Group | Post- vs never-HCT | 1.31 (0.76-2.25) | .3341 | |
Group change over time∗ | Never-HCT | Reference | ||
Group change over time∗ | Pre- vs never-HCT | 0.95 (0.89-1.02) | .1838 | |
Group change over time∗ | Post- vs never-HCT | 1.00 (0.96-1.04) | .97 | |
Instrumental activities of daily living (=14) | Group | Never-HCT | Reference | |
Group | Pre- vs never-HCT | 0.98 (0.71-1.36) | .9177 | |
Group | Post- vs never-HCT | 0.39 (0.24-0.63) | <.001 | |
Group change over time∗ | Never-HCT | Reference | ||
Group change over time∗ | Pre- vs never-HCT | 0.99 (0.93-1.06) | .8508 | |
Group change over time∗ | Post- vs never-HCT | 1.02 (0.98-1.07) | .3102 | |
ADL (=14) | Group | Never-HCT | Reference | |
Group | Pre- vs never-HCT | 1.67 (1.17-2.37) | .0043 | |
Group | Post- vs never-HCT | 0.98 (0.58-1.67) | .9542 | |
Group change over time∗ | Never-HCT | Reference | ||
Group change over time∗ | Pre- vs never-HCT | 0.98 (0.91-1.05) | .4973 | |
Group change over time∗ | Post- vs never-HCT | 1.01 (0.96-1.06) | .7107 | |
Frailty (4-MWT) (≥0.8 m/s) | Group | Never-HCT | Reference | |
Group | Pre- vs never-HCT | 1.33 (0.94-1.89) | .1119 | |
Group | Post- vs never-HCT | 2.14 (1.14-3.99) | .0171 | |
Group change over time∗ | Never-HCT | Reference | ||
Group change over time∗ | Pre- vs never-HCT | 1.11 (0.97-1.27) | .1222 | |
Group change over time∗ | Post- vs never-HCT | 0.95 (0.89-1.01) | .1092 | |
Frailty (Fried frailty index) (=0) | Group | Never-HCT | Reference | |
Group | Pre- vs never-HCT | 1.22 (0.77-1.93) | .4019 | |
Group | Post- vs never-HCT | 3.69 (1.48-9.23) | .0051 | |
Group change over time∗ | Never-HCT | Reference | ||
Group change over time∗ | Pre- vs never-HCT | 0.93 (0.81-1.06) | .2599 | |
Group change over time∗ | Post- vs never-HCT | 0.91 (0.81-1.02) | .1022 | |
Performance status (KPS) (>70) | Group | Never-HCT | Reference | |
Group | Pre- vs never-HCT | 3.00 (2.01-4.46) | <.001 | |
Group | Post- vs never-HCT | 0.66 (0.41-1.05) | .0804 | |
Group change over time∗ | Never-HCT | Reference | ||
Group change over time∗ | Pre- vs never-HCT | 0.94 (0.88-1.00) | .0464 | |
Group change over time∗ | Post- vs never-HCT | 1.00 (0.96-1.04) | .9939 |
Measure . | Parameter . | Comparison . | Estimate (95% CI) . | P . |
---|---|---|---|---|
QOL (FACT-G) (greater than mean - 0.5 standard) | Group | Never-HCT | Reference | |
Group | Pre- vs never-HCT | 1.25 (0.86-1.82) | .2512 | |
Group | Post- vs never-HCT | 1.37 (0.77-2.45) | .2859 | |
Group change over time∗ | Never-HCT | Reference | ||
Group change over time∗ | Pre- vs never-HCT | 1.02 (0.94-1.10) | .6542 | |
Group change over time∗ | Post- vs never-HCT | 0.97 (0.92-1.03) | .3057 | |
QOL (EuroQOL 5-dimensions index) (>33rd percentile) | Group | Never-HCT | Reference | |
Group | Pre- vs never-HCT | 1.26 (0.89-1.79) | .1859 | |
Group | Post- vs never-HCT | 1.41 (0.82-2.43) | .2098 | |
Group change over time∗ | Never-HCT | Reference | ||
Group change over time∗ | Pre- vs never-HCT | 1.00 (0.92-1.10) | .9112 | |
Group change over time∗ | Post- vs never-HCT | 1.00 (0.95-1.04) | .8568 | |
Depressive symptoms (PHQ-9) (<10) | Group | Never-HCT | Reference | |
Group | Pre- vs never-HCT | 1.04 (0.72-1.49) | .8368 | |
Group | Post- vs never-HCT | 2.01 (1.06-3.81) | .0323 | |
Group change over time∗ | Never-HCT | Reference | ||
Group change over time∗ | Pre- vs never-HCT | 1.19 (1.05-1.35) | .0055 | |
Group change over time∗ | Post- vs never-HCT | 0.95 (0.89-1.01) | .0913 | |
Social activities (social activity log) (≥1.13) | Group | Never-HCT | Reference | |
Group | Pre- vs never-HCT | 2.06 (1.40-3.04) | <.001 | |
Group | Post- vs never-HCT | 1.27 (0.70-2.32) | .4344 | |
Group change over time∗ | Never-HCT | Reference | ||
Group change over time∗ | Pre- vs never-HCT | 0.93 (0.87-0.99) | .0346 | |
Group change over time∗ | Post- vs never-HCT | 1.00 (0.95-1.05) | .9789 | |
Perceived social support (ENRICHD social support inventory) (greater than mean - 0.5 standard) | Group | Never-HCT | Reference | |
Group | Pre- vs never-HCT | 1.76 (1.21-2.57) | .0033 | |
Group | Post- vs never-HCT | 1.31 (0.76-2.25) | .3341 | |
Group change over time∗ | Never-HCT | Reference | ||
Group change over time∗ | Pre- vs never-HCT | 0.95 (0.89-1.02) | .1838 | |
Group change over time∗ | Post- vs never-HCT | 1.00 (0.96-1.04) | .97 | |
Instrumental activities of daily living (=14) | Group | Never-HCT | Reference | |
Group | Pre- vs never-HCT | 0.98 (0.71-1.36) | .9177 | |
Group | Post- vs never-HCT | 0.39 (0.24-0.63) | <.001 | |
Group change over time∗ | Never-HCT | Reference | ||
Group change over time∗ | Pre- vs never-HCT | 0.99 (0.93-1.06) | .8508 | |
Group change over time∗ | Post- vs never-HCT | 1.02 (0.98-1.07) | .3102 | |
ADL (=14) | Group | Never-HCT | Reference | |
Group | Pre- vs never-HCT | 1.67 (1.17-2.37) | .0043 | |
Group | Post- vs never-HCT | 0.98 (0.58-1.67) | .9542 | |
Group change over time∗ | Never-HCT | Reference | ||
Group change over time∗ | Pre- vs never-HCT | 0.98 (0.91-1.05) | .4973 | |
Group change over time∗ | Post- vs never-HCT | 1.01 (0.96-1.06) | .7107 | |
Frailty (4-MWT) (≥0.8 m/s) | Group | Never-HCT | Reference | |
Group | Pre- vs never-HCT | 1.33 (0.94-1.89) | .1119 | |
Group | Post- vs never-HCT | 2.14 (1.14-3.99) | .0171 | |
Group change over time∗ | Never-HCT | Reference | ||
Group change over time∗ | Pre- vs never-HCT | 1.11 (0.97-1.27) | .1222 | |
Group change over time∗ | Post- vs never-HCT | 0.95 (0.89-1.01) | .1092 | |
Frailty (Fried frailty index) (=0) | Group | Never-HCT | Reference | |
Group | Pre- vs never-HCT | 1.22 (0.77-1.93) | .4019 | |
Group | Post- vs never-HCT | 3.69 (1.48-9.23) | .0051 | |
Group change over time∗ | Never-HCT | Reference | ||
Group change over time∗ | Pre- vs never-HCT | 0.93 (0.81-1.06) | .2599 | |
Group change over time∗ | Post- vs never-HCT | 0.91 (0.81-1.02) | .1022 | |
Performance status (KPS) (>70) | Group | Never-HCT | Reference | |
Group | Pre- vs never-HCT | 3.00 (2.01-4.46) | <.001 | |
Group | Post- vs never-HCT | 0.66 (0.41-1.05) | .0804 | |
Group change over time∗ | Never-HCT | Reference | ||
Group change over time∗ | Pre- vs never-HCT | 0.94 (0.88-1.00) | .0464 | |
Group change over time∗ | Post- vs never-HCT | 1.00 (0.96-1.04) | .9939 |
Adjusted for age group, sex, comorbidity score group per AML composite model, disease type (MDS/myeloproliferative disorder or AML), and induction treatment regimen intensity as appropriate.